Immunomodulation of Fucosyl-lactose and Lacto-N-fucopentaose on Mononuclear Cells from Multiple Sclerosis and Healthy Subjects

Overview

Journal Int J Biomed Sci

Specialty General Medicine

Date 2013 May 16

PMID 23674973

Citations 9

Authors

S Sotgiu

G Arru

M L Fois

A Sanna

M Musumeci

G Rosati

S Musumeci

Affiliations

Soon will be listed here.

Abstract

The 1,2-fucosyl-oligosaccharides, and among these the 2'-fucosyl-lactose (2'-FL) and lacto-N-fucopentaose (LNFP)-I, are quantitatively the most represented oligosaccharides of human milk. They are also seen to represent an important immune device to prevent nursing infants from severe infectious diarrhoea. Recent evidences show that the appearance of 2'-FL and LNFP-I in human colostrums is synchronised with the macrophage inhibition and that LNFP-III induces a Th2 response from the mouse peripheral immune system. Since mannosyl-fucosyl receptors are described on the macrophage surface, all these evidences allow us to investigate on the possible immune function of human 2'-FL and LNFP-I in vitro on LPS-activated mononuclear cells (MNC) from 12 patients with multiple sclerosis (MS) and 20 matched health controls (HC). We found that 2'-FL and LNFP-I significantly decrease, to a different extent, the MNC proliferation from both HC and MS patients, in a linear and dose-dependent manner. 2'-FL and LNFP-I also reduce the production of IL-12 and IFN-γ, particularly in MS patients as compared to HC (p=0.01 and p<0.001, respectively), while increasing that of IL-10. The overall immunomodulatory effect of 2'-FL and LNFP I here presented may represent a future therapeutic option for the abnormal immune response found in some monocyte-mediated diseases.

Citing Articles

Interactions of human milk oligosaccharides with the immune system.

Slater A, Hickey R, Davey G Front Immunol. 2025; 15:1523829.

PMID: 39877362 PMC: 11772441. DOI: 10.3389/fimmu.2024.1523829.

Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents.

Rousseaux A, Brosseau C, Le Gall S, Piloquet H, Barbarot S, Bodinier M Front Immunol. 2021; 12:680911.

PMID: 34108974 PMC: 8180913. DOI: 10.3389/fimmu.2021.680911.

In Love with Shaping You-Influential Factors on the Breast Milk Content of Human Milk Oligosaccharides and Their Decisive Roles for Neonatal Development.

Hundshammer C, Minge O Nutrients. 2020; 12(11).

PMID: 33233832 PMC: 7699834. DOI: 10.3390/nu12113568.

Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health.

Walsh C, Lane J, Van Sinderen D, Hickey R J Funct Foods. 2020; 72:104074.

PMID: 32834834 PMC: 7332462. DOI: 10.1016/j.jff.2020.104074.

Exposure of Intestinal Epithelial Cells to 2'-Fucosyllactose and CpG Enhances Galectin Release and Instructs Dendritic Cells to Drive Th1 and Regulatory-Type Immune Development.

Ayechu-Muruzabal V, Overbeek S, Kostadinova A, Stahl B, Garssen J, Vant Land B Biomolecules. 2020; 10(5).

PMID: 32438601 PMC: 7278199. DOI: 10.3390/biom10050784.

References

Bry L, Falk P, Midtvedt T, Gordon J . A model of host-microbial interactions in an open mammalian ecosystem. Science. 1996; 273(5280):1380-3. DOI: 10.1126/science.273.5280.1380. View

Klegeris A, Budd T, Greenfield S . Acetylcholinesterase-induced respiratory burst in macrophages: evidence for the involvement of the macrophage mannose-fucose receptor. Biochim Biophys Acta. 1996; 1289(1):159-68. DOI: 10.1016/0304-4165(95)00105-0. View

Okano M, Satoskar A, Nishizaki K, Harn Jr D . Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol. 2001; 167(1):442-50. DOI: 10.4049/jimmunol.167.1.442. View

Newburg D, Ruiz-Palacios G, Morrow A . Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 2005; 25:37-58. DOI: 10.1146/annurev.nutr.25.050304.092553. View

Morrow A, Ruiz-Palacios G, Jiang X, Newburg D . Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr. 2005; 135(5):1304-7. DOI: 10.1093/jn/135.5.1304. View

Bjork S, Breimer M, Hansson G, Karlsson K, Leffler H . Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol Chem. 1987; 262(14):6758-65. View

Musumeci M, Simpore J, DAgata A, Sotgiu S, Musumeci S . Oligosaccharides in colostrum of Italian and Burkinabe women. J Pediatr Gastroenterol Nutr. 2006; 43(3):372-8. DOI: 10.1097/01.mpg.0000228125.70971.af. View

Newburg D . Oligosaccharides and glycoconjugates in human milk: their role in host defense. J Mammary Gland Biol Neoplasia. 1996; 1(3):271-83. DOI: 10.1007/BF02018080. View

Musumeci M, Malaguarnera L, Simpore J, Barone R, Whalen M, Musumeci S . Chitotriosidase activity in colostrum from African and Caucasian women. Clin Chem Lab Med. 2005; 43(2):198-201. DOI: 10.1515/CCLM.2005.034. View

10.

Hooper L, Xu J, Falk P, Midtvedt T, Gordon J . A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A. 1999; 96(17):9833-8. PMC: 22296. DOI: 10.1073/pnas.96.17.9833. View

11.

Gusils C, Morata V, Gonzalez S . Determination of bacterial adhesion to intestinal mucus. Methods Mol Biol. 2004; 268:411-5. DOI: 10.1385/1-59259-766-1:411. View

12.

Imitola J, Chitnis T, Khoury S . Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther. 2005; 106(2):163-77. DOI: 10.1016/j.pharmthera.2004.11.007. View

13.

Kornek B, Lassmann H . Neuropathology of multiple sclerosis-new concepts. Brain Res Bull. 2003; 61(3):321-6. DOI: 10.1016/s0361-9230(03)00095-9. View

14.

Hoff S, van Oosten B, Verweij C, Drager A, Ader H, van Houwelingen J . Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol. 1999; 45(6):695-703. DOI: 10.1002/1531-8249(199906)45:6<695::aid-ana3>3.0.co;2-r. View

15.

Finne J, Breimer M, Hansson G, Karlsson K, Leffler H, Vliegenthart J . Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J Biol Chem. 1989; 264(10):5720-35. View

16.

Coyne M, Reinap B, Lee M, Comstock L . Human symbionts use a host-like pathway for surface fucosylation. Science. 2005; 307(5716):1778-81. DOI: 10.1126/science.1106469. View

17.

Becher B, Giacomini P, Pelletier D, McCrea E, Prat A, Antel J . Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann Neurol. 1999; 45(2):247-50. View

18.

Ersoy E, Kus C, Sener U, Coker I, Zorlu Y . The effects of interferon-beta on interleukin-10 in multiple sclerosis patients. Eur J Neurol. 2005; 12(3):208-11. DOI: 10.1111/j.1468-1331.2004.00986.x. View

19.

Newburg D, Ruiz-Palacios G, Altaye M, Chaturvedi P, Meinzen-Derr J, de Lourdes Guerrero M . Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology. 2003; 14(3):253-63. DOI: 10.1093/glycob/cwh020. View

20.

Sarkar K, Sarkar H, Kole L, Das P . Receptor-mediated endocytosis of fucosylated neoglycoprotein by macrophages. Mol Cell Biochem. 1996; 156(2):109-16. DOI: 10.1007/BF00426332. View